Spectrum of epithelial cell abnormalities of uterine cervix in a cervical cancer screening programme: Implications for resource limited settings

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 134, Issue 2, 2007, Pages 238-242

  Gupta, Sanjay ^a   Sodhani, Pushpa ^a   Halder, Kaushik ^a   Chachra, Krishan Lal ^a   Sardana, Sarita ^a   Singh, Veena ^a   Sehgal, Ashok ^a  

^a Institute of Cytology and Preventive Oncology (ICMR)   (India)

Author keywords

Atypical squamous cells (ASC); Cervical cancer; Epithelial cell abnormalities (ECA); Screening; Squamous intraepithelial lesion (SIL)

Indexed keywords

VIRUS DNA;

ADULT; AGED; ARTICLE; CANCER CYTODIAGNOSIS; CANCER INVASION; CANCER SCREENING; CARCINOMA IN SITU; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; ONSET AGE; PAPANICOLAOU TEST; PRIORITY JOURNAL; RESOURCE ALLOCATION; SQUAMOUS CELL; UTERINE CERVIX CANCER; UTERINE CERVIX CYTOLOGY; UTERINE CERVIX EPITHELIUM; WORLD HEALTH ORGANIZATION;

EID: 34548842239     PISSN: 03012115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejogrb.2006.07.022     Document Type: Article

References (25)

1. Ferlay J., Bray F., and Pisani P. Globocon 2000: cancer incidence, mortality and prevalence worldwide. Version 1.0 IARC Cancer Base No. 5 (2001), IARC Press, Lyon
2. Holowaty P., Miller A.B., Rohan T., and To T. Natural history of dysplasia of uterine cervix. JNCI 91 (1999) 252-258
3. Sankaranarayana R., Nene B.M., Dinshaw K., et al. Early detection of cervical cancer with visual inspection methods: a summary of completed and ongoing studies in India. Salud Publica Mexico 45 Suppl. (2003) S399-S407
4. National Cancer Registry Programme. Bienneal Report 188-189. An epidemiological study. Indian Council of Medical Research, New Delhi, 1992.
5. Day N.E. The epidemiological basis for evaluating different screening policies. In: Hakama M., Miller A.B., and Day N.E. (Eds). Screening for cancer of uterine cervix vol. 76 (1986), IARC Scientific Publication, Lyon 213-217
6. World Health Organization. National Cancer Control Programmes: policies and managerial guidelines, 2nd ed., Geneva.
7. Solomon D., et al. Bethesda 2001 workshop: the 2001 Bethesda system-terminology for reporting the results of cervical cytology. JAMA 287 (2002) 2114-2117
8. Hakama M., Chamberlain J., Day N.E., Miller A.B., and Prorok P.C. Evaluation of screening programmes for gynecological cancers. Br J Cancer 52 (1985) 669-673
9. Miller A.B., Chamberlain J., Day N.E., Hakama M., and Prorok P.C. Report on a workshop of the UICC project on evaluation of screening for cancer. Int J Cancer 46 (1990) 761-769
10. Elhakeem H.A., Al-Ghamdi A.S., and Al-Maghrabi J.A. Cytopathological pattern of cervical Pap smear according to the Bethesda system in Southwestern Saudi Arabia. Saudi Med J 26 (2005) 588-592
11. Jamal A., and Al-Maghrabi J.A. Profile of Pap smear cytology in Western region of Saudi Arabia. Saudi Med J 24 (2003) 1225-1229
12. Waddel C.A. The influence of the cervix on the smear quality. An audit of cervical smears taken post-colposcopic management of intraepithelial neoplasia. Cytopathology 8 (1997) 274-281
13. Nuovo G.J., Cottral S., and Richart R.M. Occult human papilloma virus infection of uterine cervix in post-menopausal women. Am J Obstet Gynecol 160 (1989) 340-344
14. Teaff N.L., Malone Jr. J.M., Ginsburg K.A., Bartles L.W., and Haigler B.B. Cervical dysplasia in post-menopausal female: diagnosis and treatment. Int J Gynecol Obstet 34 (1990) 145-149
15. Ferenczy A., Gelfand M.M., Franco E., and Mansour N. Human papilloma virus infection in post-menopausal women with and without hormone therapy. Obstet Gynecol 90 (1997) 7-11
16. Sheils L.A., and Wilbur D.C. Atypical squamous cells of undetermined significance: stratification of the risk of association with, or progression to, squamous intraepithelial lesions based on morphologic subcategorization. Acta Cytol 41 (1997) 1065-1072
17. Boman F., Duhamel A., Trench Q.D., Deken V., Leroy J.L., and Beuscart R. Evaluation of cytological screening for cancers and precancerous lesions of the cervix. Bull Cancer 90 (2003) 643-647
18. Rader A.E., Rose P.G., Rodriguez M., Mansbacher S., Pitlik D., and Abdul-Karim F.W. Atypical squamous cells of undetermined significance in women over 55. Comparison with general population and implications for management. Acta Cytol 43 (1999) 357-362
19. Keating J.T., and Wang H.H. Significance of a diagnosis of atypical squamous cells of undetermined significance for Papanicoloau smears in peri-menopausal and post-menopausal women. Cancer 93 (2001) 100-105
20. Selvaggi S.M. Reporting of atypical squamous cells, cannot exclude a high grade squamous intraepithelial lesion (ASC-H) on cervical samples: is it significant?. Diagn Cytopathol 29 (2003) 38-41
21. Duncan L.D., and Jacob S.V. Atypical squamous cells, cannot exclude a high grade squamous intraepithelial lesion: the practice experience of a hospital-based reference laboratory with this new Bethesda system diagnostic category. Diagn Cytopathol 32 (2005) 243-246
22. Louro A.P., Roberson J., Eltoum I., and Chhieng D.C. A typical squamous cells, cannot exclude HSIL. A follow-up study of conventional and liquid-based preparations in a high risk population. Am J Clin Pathol 120 (2003) 392-397
23. Zweizig S., Noller K., Reale F., Collis S., and Reseguie L. Neoplasia associated with atypical glandular cells of undetermined significance on cervical cytology. Gynecol Oncol 65 (1997) 314-318
24. Goff B.A., Atansoff P., Brown E., Muntz H.G., Bell D.A., and Rice L.W. Endocervical glandular atypia in Papanicolaou smears. Obstet Gynecol 79 (1992) 101-104
25. Balbi G.C., Cardone A., Zarcone R., Visconti S., and Del Piano L. AGUS and ASCUS: different incidences in pre- and post-menopausal women. Eur J Gynecol Oncol 25 (2004) 603-605